P&G nabs Nioxin
This article was originally published in The Rose Sheet
Executive Summary
With purchase of Nioxin Research Laboratories, announced Sept. 3, P&G gains range of innovative professional hair-care products that focus on the scalp to improve appearance of thinning hair, firm says. Nioxin offerings currently are distributed through salons and salon stores in more than 40 countries, P&G says. Acquisition is in harmony with P&G's strategy of focusing on "faster growing, higher margin and more asset-efficient businesses," according to release. The personal care giant will keep Nioxin's brand portfolio, organization and distribution network in place in order to strengthen its commitment to growth in professional salon channel; Brian Graham will stay on as CEO of Nioxin, P&G notes. "This acquisition is a great strategic fit given P&G's leadership and proven strength in its retail scalp care business. Further, P&G's global scale creates opportunities to further grow the Nioxin brand in key markets around the world," says Robert Jongstra, president, P&G Professional Care
You may also be interested in...
Pro Hair-Care Firm Nioxin Looks To Expand Global Reach As P&G Subsidiary
Procter & Gamble's acquisition of Nioxin positions the professional hair-care company to expand its reach globally and potentially become a "billion dollar brand," according to Nioxin CEO Brian Graham
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.
Generic Or Innovator? Sandoz Sues CMS Over Potential Change In Rebate Classification
Sandoz argued against paying higher rebates for two of its drugs via the Centers for Medicare and Medicaid Services’ Medicaid drug rebate program in a US court six years after the suggestion was first made.